{"rows":[{"id":922,"title":"Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.","authors":"Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G","journal":"Deutsches Arzteblatt international","publication_date":"2024-12-27","publication_year":2024,"doi":"10.3238/arztebl.m2024.0224","pubmed_id":"39628414","openalex_id":"https://openalex.org/W4405029114","source_url":"https://pubmed.ncbi.nlm.nih.gov/39628414/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:05","bibtex":null,"source_record_id":"PMID:39628414","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39628414/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39628414","source_url":"https://pubmed.ncbi.nlm.nih.gov/39628414/","doi":"10.3238/arztebl.m2024.0224","pmid":"39628414","publication_date":"2024-12-27","importer_version":"2.1.3","text_redistributed":false}}],"total":1,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Deutsches Arzteblatt international","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}